These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32606465)

  • 1. CRISPR gene editing in human embryos wreaks chromosomal mayhem.
    Ledford H
    Nature; 2020 Jul; 583(7814):17-18. PubMed ID: 32606465
    [No Abstract]   [Full Text] [Related]  

  • 2. The CRISPR-baby scandal: what's next for human gene-editing.
    Cyranoski D
    Nature; 2019 Feb; 566(7745):440-442. PubMed ID: 30809070
    [No Abstract]   [Full Text] [Related]  

  • 3. Narrow path charted for editing genes of human embryos.
    Cohen J
    Science; 2020 Sep; 369(6509):1283. PubMed ID: 32913081
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic Germline Editing: Sense and Sensibility.
    Adashi EY; Cohen IG
    Trends Genet; 2020 May; 36(5):315-317. PubMed ID: 31982142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for inborn errors of immunity: Base editing comes into play.
    Malech HL; Notarangelo LD
    Cell; 2023 Mar; 186(7):1302-1304. PubMed ID: 37001495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 therapeutics for liver diseases.
    Aravalli RN; Steer CJ
    J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Therapeutic Genome Editing in China.
    Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
    Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.
    Alanis-Lobato G; Zohren J; McCarthy A; Fogarty NME; Kubikova N; Hardman E; Greco M; Wells D; Turner JMA; Niakan KK
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new milestone in human embryo editing].
    Jordan B
    Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.
    Wu SS; Li QC; Yin CQ; Xue W; Song CQ
    Theranostics; 2020; 10(10):4374-4382. PubMed ID: 32292501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of creating genetically modified children using genome editing.
    Ishii T
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):418-423. PubMed ID: 28885275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.
    Gumer JM
    New Bioeth; 2019 Jun; 25(2):137-152. PubMed ID: 31130112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome editing for the reproduction and remedy of human diseases in mice.
    Hara S; Takada S
    J Hum Genet; 2018 Feb; 63(2):107-113. PubMed ID: 29180644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
    Plaza Reyes A; Lanner F
    Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geneticists retract study suggesting first CRISPR babies might die early.
    Callaway E
    Nature; 2019 Oct; 574(7778):307. PubMed ID: 31616098
    [No Abstract]   [Full Text] [Related]  

  • 18. Marker-free genome editing in Ustilago trichophora with the CRISPR-Cas9 technology.
    Huck S; Bock J; Girardello J; Gauert M; Pul Ü
    RNA Biol; 2019 Apr; 16(4):397-403. PubMed ID: 29996713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime Time for Genome Editing?
    Urnov FD
    N Engl J Med; 2020 Jan; 382(5):481-484. PubMed ID: 31995698
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome editing: 4 big questions.
    Tauxe W
    Nature; 2015 Dec; 528(7580):S17. PubMed ID: 26630595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.